Pharmacogenomics of Non-Small Cell Lung Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1875-6204|5|3|228-234

ISSN： 1570-1603

Source： Current Pharmacogenomics, Vol.5, Iss.3, 2007-09, pp. : 228-234

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Non–Small Cell Lung Cancer

By  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 6, Iss. 3, 2008-03 ,pp. : 228-228

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Pharmacogenomics of gemcitabine in non-small-cell lung cancer and other solid tumors

By Danesi Romano   Altavilla Giuseppe   Giovannetti Elisa   Rosell Raffael  

Pharmacogenomics, Vol. 10, Iss. 1, 2009-01 ,pp. : 69-80

Future Medicine

Access to resources Recommend Favorite

Pemetrexed for the treatment of non-small cell lung cancer

By Genova Carlo  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 11, 2013-08 ,pp. : 1545-1558

Informa Healthcare

Access to resources Recommend Favorite

Economics of Treatments for Non-Small Cell Lung Cancer

By Chouaid Christos   Atsou Kukovi  

PharmacoEconomics, Vol. 27, Iss. 2, 2009-01 ,pp. : 113-125

Adis International

Access to resources Recommend Favorite

Taxanes for advanced non-small cell lung cancer

By Ramalingam Sakkaraiappan   Belani Chandra P  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 12, 2002-12 ,pp. : 1693-1709

Informa Healthcare

Access to resources Recommend Favorite